Media ReleasesStar Combo Pharma

View All Star Combo Pharma News

Star Combo Pharma, Corporate Overview - October 2018

Key Messages

- Inaugural ASX financial result – record full year revenue of $10.9million

- Gross Profit is $4.49million, up 11.2%, with gross margin at 41%

- Record sales of company owned brand products via pharmacies stores to $0.78million from $51k in FY17.

- Working capital has increased by 65% to $13million, reflects the working capital requirement associated with the organic revenue growth.

- Solid balance sheet include $10.7million in cash and no debt.

- Normalised profit of $2.17million with add back of one off expenses

- One off expenses represent investment in building company’s brand awareness and strengthening relationships with business partners

- Strong organic growth and business acquisition targets in the pipeline

For further information please download PDF attached:
Download this document